We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
(+14%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$200M |
| 2 |
Amazon
AMZN
|
+$126M |
| 3 |
Deutsche Bank
DB
|
+$109M |
| 4 |
Intuitive Surgical
ISRG
|
+$92.2M |
| 5 |
Wells Fargo
WFC
|
+$83.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$126M |
| 2 |
Abbott
ABT
|
+$79.1M |
| 3 |
VF Corp
VFC
|
+$49M |
| 4 |
JPMorgan Chase
JPM
|
+$48.5M |
| 5 |
BioNTech
BNTX
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.46% |
| 3 | Financials | 11.88% |
| 4 | Communication Services | 9.65% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Nektar Therapeutics
NKTR
$2.53B
| $933K | ﹤0.01% |
3,600
| – | – |
|
|
NGM
927
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $933K | ﹤0.01% |
47,100
| – | – |
|
928
Southwest Gas
SWX
$6.56B
| $929K | ﹤0.01% |
14,373
| – | – |
|
929
VirnetX Holding Corp
VHC
$60M
| $924K | ﹤0.01% |
10,300
+6,500
| +171% | +$611K |
|
930
Bunge Global
BG
$21.6B
| $921K | ﹤0.01% |
11,668
-47
| -0.4% | -$3.97K |
|
931
Advanced Drainage Systems
WMS
$10.7B
| $920K | ﹤0.01% |
8,000
+1,000
| +14% | +$111K |
|
932
Core Laboratories
CLB
$561M
| $917K | ﹤0.01% |
+24,000
| New | +$860K |
|
|
DEA
933
Easterly Government Properties
DEA
$1.13B
| $913K | ﹤0.01% |
17,600
| – | – |
|
934
Greif
GEF
$4.97B
| $912K | ﹤0.01% |
15,511
| – | – |
|
935
Editas Medicine
EDIT
$432M
| $911K | ﹤0.01% |
19,800
| – | – |
|
936
Sibanye-Stillwater
SBSW
$7.55B
| $903K | ﹤0.01% |
55,190
| – | – |
|
937
KB Financial Group
KB
$42.4B
| $897K | ﹤0.01% |
18,186
| – | – |
|
938
XPO
XPO
$23.5B
| $895K | ﹤0.01% |
18,493
-16,461
| -47% | -$804K |
|
939
Amdocs
DOX
$6.22B
| $889K | ﹤0.01% |
11,715
-62,530
| -84% | -$4.83M |
|
940
Otter Tail
OTTR
$3.88B
| $889K | ﹤0.01% |
18,729
-5,528
| -23% | -$265K |
|
941
U-Haul Holding Co
UHAL
$14.4B
| $888K | ﹤0.01% |
15,530
-17,300
| -53% | -$1.01M |
|
942
Tenable Holdings
TENB
$4.04B
| $885K | ﹤0.01% |
20,850
+8,600
| +70% | +$349K |
|
|
BLUE
943
DELISTED
bluebird bio
BLUE
| $882K | ﹤0.01% |
2,287
| – | – |
|
944
Pinnacle West Capital
PNW
$12B
| $879K | ﹤0.01% |
10,900
-2,613
| -19% | -$221K |
|
945
Veracyte
VCYT
$3.72B
| $878K | ﹤0.01% |
21,400
| – | – |
|
946
Alkermes
ALKS
$8.29B
| $876K | ﹤0.01% |
36,550
| – | – |
|
947
Qualys
QLYS
$6.43B
| $868K | ﹤0.01% |
8,590
| – | – |
|
948
Axsome Therapeutics
AXSM
$11.4B
| $867K | ﹤0.01% |
12,650
| – | – |
|
949
Xerox
XRX
$427M
| $865K | ﹤0.01% |
37,900
| – | – |
|
950
Opko Health
OPK
$1.04B
| $863K | ﹤0.01% |
214,874
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review
As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
- DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
- DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
- DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.